Ezetimibe Tablets (Ezetimibe)

Adult dosage

The recommended dose of this medication is 10 mg once daily, administered regardless of meals. When co-administered with HMG-CoA reductase inhibitors, it should be started at the recommended initial dose of the HMG-CoA reductase inhibitor, and if already on a high dose of the HMG-CoA reductase inhibitor, this medication should be added while maintaining the dose of the HMG-CoA reductase inhibitor. This medication is

This medication should not be used in patients who have had allergic reactions to any of its components. Patients with active liver disease or persistently elevated liver enzymes of unknown origin should avoid the combination of this medication with specific lipid-lowering agents. Women who are pregnant or nursing are prohibited from using this medication in combination with specific lipid-lowering agents, so women of childbearing age should consult a doctor before use. Patients with severely impaired liver function, gallbladder disease, or severe renal failure should not combine this medication with specific lipid-lowering agents. In patients with moderate to severe liver function impairment, increased exposure to this medication may occur, leading to unexpected side effects, so its use is not recommended in such cases. This medication is generally well tolerated, but side effects such as headache, abdominal pain, diarrhea, fatigue, joint pain, low back pain, cough, and others may occur; if unusual symptoms arise, consult a doctor. When used in combination with specific lipid-lowering agents, liver enzyme levels may rise, so regular liver function tests are necessary. Notify a doctor immediately if symptoms of muscle pain, muscle weakness, or myasthenia appear, and discontinue medication as needed. Patients with severely impaired renal function also require caution, especially when using this medication with specific lipid-lowering agents, and renal function should be closely monitored. This medication can interact with other drugs; special care should be taken when used with cholestyramine, fenofibrate, cyclosporine, anticoagulants, and others, as warranted by a doctor's instructions. The use of this medication is restricted during pregnancy or lactation, and it should be considered carefully for potential effects on the fetus or infant. Use in children under 6 years is not recommended, and in children or adolescents aged 6 and older, strict adherence to a physician's guidance is necessary. Elderly patients may exhibit particularly sensitive reactions, so caution is advised. In case of overdose, no specific antidote is available; treatment should be symptomatic, following doctor's instructions. This medication should be kept out of reach of children and should not be transferred to another container.

Serious side effects

Hives, severe swelling (edema), hypersensitivity reactions (anaphylaxis, angioedema), liver dysfunction (hepatitis, elevated liver amino transferase levels, potential jaundice), myopathy, rhabdomyolysis, severe skin adverse reactions, renal failure, severe swelling or urination abnormalities, hypertension, serious neurological symptoms (may include dizziness, sensory disturbances), respiratory issues (difficulty breathing, potential breathing abnormalities accompanied by coughing)

Mild side effects

• Fatigue
• abdominal pain
• diarrhea
• viral infections
• pharyngitis
• sinusitis
• joint pain
• low back pain
• cough
• chest pain

This medication should be stored in a tightly sealed container to protect from air and moisture. Additionally, it is important to store it at room temperature between 1°C and 30°C to maintain its effectiveness.

Appearance

White to off-white elongated tablets

Package unit

10 tablets/PTP, 100 tablets/bottle